Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Biotech Stocks Emerge Unscathed And Ready To Go

Article By:
Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EST
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Immunomedics - Chart Of The Day

Article By:
Jim Van Meerten
Saturday, August 26, 2017 8:59 AM EST
Since the Trend Spotter signaled a buy on 8/22 the stock gained 9.61%.
In this article: IMMU
Seattle Genetics Eliminates $2 Billion Deal With Immunomedics

Article By:
Terry Chrisomalis
Saturday, May 6, 2017 1:39 PM EST
On Friday, it was announced that Seattle Genetics had ended a potential $2 billion deal with Immunomedics. The initial deal was proposed back in February of this year.
Jefferies Sees 'Attractive Buying Opportunities' In Biotech

Article By:
The Fly
Tuesday, October 18, 2016 10:16 AM EST
The Jefferies Biotechnology team sees "attractive buying opportunities" amidst the pre-election weakness. They recommend using the weakness to buy select names ahead of a potential improvement in sentiment.